McKesson Corporation (MCK)vsQuipt Home Medical Corp (QIPT)
MCK
McKesson Corporation
$807.85
-0.76%
HEALTHCARE · Cap: $99.71B
QIPT
Quipt Home Medical Corp
$3.65
0.00%
HEALTHCARE · Cap: $162.30M
Smart Verdict
WallStSmart Research — data-driven comparison
McKesson Corporation generates 150088% more annual revenue ($397.96B vs $264.97M). MCK leads profitability with a 1.1% profit margin vs -0.0%. MCK earns a higher WallStSmart Score of 62/100 (C+).
MCK
Buy62
out of 100
Grade: C+
QIPT
Hold40
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+63.8%
Fair Value
$2632.66
Current Price
$807.85
$1824.81 discount
Margin of Safety
+78.7%
Fair Value
$16.68
Current Price
$3.65
$13.03 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Growing faster than its price suggests
Earnings expanding 38.0% YoY
Generating 1.1B in free cash flow
Reasonable price relative to book value
Areas to Watch
ROE of 0.0% — below average capital efficiency
1.1% margin — thin
Operating margin of 1.6%
0.3% revenue growth
Smaller company, higher risk/reward
Operating margin of 0.0%
ROE of -0.1% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : MCK
The strongest argument for MCK centers on Debt/Equity, Altman Z-Score, Market Cap. Revenue growth of 11.4% demonstrates continued momentum. PEG of 0.99 suggests the stock is reasonably priced for its growth.
Bull Case : QIPT
The strongest argument for QIPT centers on Price/Book.
Bear Case : MCK
The primary concerns for MCK are Return on Equity, Profit Margin, Operating Margin. Thin 1.1% margins leave little buffer for downturns.
Bear Case : QIPT
The primary concerns for QIPT are Revenue Growth, Market Cap, Operating Margin.
Key Dynamics to Monitor
MCK profiles as a value stock while QIPT is a turnaround play — different risk/reward profiles.
QIPT carries more volatility with a beta of 0.49 — expect wider price swings.
MCK is growing revenue faster at 11.4% — sustainability is the question.
MCK generates stronger free cash flow (1.1B), providing more financial flexibility.
Bottom Line
MCK scores higher overall (62/100 vs 40/100) and 11.4% revenue growth. QIPT offers better value entry with a 78.7% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
McKesson Corporation
HEALTHCARE · MEDICAL DISTRIBUTION · USA
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.
Visit Website →Quipt Home Medical Corp
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?